Skip to main content
Clinical Trials/NCT01388751
NCT01388751CompletedNot Applicable

Night Splinting After 6 to 8 Weeks of Continuous Splinting for Mallet Finger

Massachusetts General Hospital2 sites in 1 country52 target enrollmentStarted: November 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
52
Locations
2
Primary Endpoint
Extensor Lag

Study Overview

Brief Summary

Do patients that night splint for 1 month after 6-8 weeks of continuous splinting for a mallet injury have the same extensor lag 4 months after initiating treatment as patients that do not perform night splinting?

Secondary Question: Is night splinting a predictor of DASH score or patient satisfaction (on a 5-Point Likert scale)?

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All adult, English-speaking patients in the practice of Dr. Jesse Jupiter, Dr. Chaitanya Mudgal, or Dr. David Ring electing splint treatment for mallet deformity will be invited to enroll on their follow-up visit 6-8 weeks after initiating splint treatment.

Exclusion Criteria

  • Open lesions
  • Mallet fracture more than 2 weeks old
  • Mallet fracture with subluxation of the distal interphalangeal joint.

Outcomes

Primary Outcomes

Extensor Lag

Time Frame: 4 months

Null Hypothesis: Patients that night splint for 1 month after 6-8 weeks of continuous splinting for a mallet injury have the same extensor lag 4 months after initiating treatment as patients that do not perform night splinting.

Secondary Outcomes

  • DASH score(4 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

David C. Ring, MD

Principal Investigator; Director of Research, Hand Service

Massachusetts General Hospital

Study Sites (2)

Loading locations...

Similar Trials

Mallet Finger Splinting Study | Clinical Trial